WIERENGA WENDELL 4
4 · Dermata Therapeutics, Inc. · Filed Aug 17, 2021
Insider Transaction Report
Form 4
WIERENGA WENDELL
Director
Transactions
- Conversion
Common Stock
2021-08-17+8,163→ 13,041 total - Conversion
Series 1d Preferred Stock
2021-08-17−55,078→ 0 total→ Common Stock (8,163 underlying)
Footnotes (1)
- [F1]The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the "IPO"). The Series 1d Preferred Stock was convertible at any time and had no expiration date.